Autoimmune Encephalitis in Children.

Area of Science:

• Neurology
• Immunology
• Pediatrics

Background:

• Autoimmune encephalitis encompasses central nervous system (CNS) inflammatory disorders often linked to antibodies targeting neuronal surface proteins.
• While some forms lack identified antibodies, others present with neurological symptoms like seizures and movement disorders, particularly in children.
• Psychiatric symptoms, though less common initially, can include aggression and agitation.

Purpose of the Study:

• To review the various forms of autoimmune encephalitis.
• To discuss diagnostic and treatment approaches for autoimmune encephalitis.
• To examine the outcomes and prognosis for children diagnosed with autoimmune encephalitis.

Main Methods:

• Literature review of autoimmune encephalitis.
• Analysis of diagnostic criteria and therapeutic strategies.
• Evaluation of prognostic factors and patient outcomes.

Main Results:

• Neurological manifestations are often more prominent than psychiatric symptoms in pediatric autoimmune encephalitis.
• First-line treatments include steroids, IVIg, and plasmapheresis.
• Rituximab and cyclophosphamide are options for refractory or relapsing cases.

Conclusions:

• Prompt diagnosis and early intervention are crucial for improving outcomes and reducing relapse rates in autoimmune encephalitis.
• Understanding the diverse clinical presentations and treatment responses is key to managing pediatric autoimmune encephalitis.
• This review provides insights into the prognosis of children affected by autoimmune encephalitis.